ENDOCRINOLOGIST – Oakville Trafalgar Memorial Hospital Site, Ontario

The Department of Medicine at Halton Healthcare, Oakville Site, is seeking an Endocrinologist to provide ambulatory diabetes care to the community through the Halton Diabetes Program as well as inpatient endocrinology, and diabetes consultations. The successful candidate would join 3 current endocrinologists and would work collaboratively with diabetes educators. Diabetes clinic responsibility is 0.5 day/week, and balanced alongside a community endocrinology practice in these rapidly growing communities.
Sharing in internal medicine on-call coverage will be required. On-call frequency will be 1 to 2 shifts per month. Further participation in a daytime internal medicine consultation service is optional.
The Halton Diabetes Program is a regional program providing diabetes services to residents in the communities of Burlington, Halton Hills, Milton and Oakville. The program provides education and care to adults with a diagnosis of type 1, type 2, prediabetes/IGT and gestational diabetes. The program serves over 5500 patients with over 15,000 visits.
Candidates must have an independent license or be eligible for independent license with the College of Physicians & Surgeons of Ontario (CPSO). They must have fellowship standing in the
Royal College of Physicians & Surgeons of Canada (FRCPC) in Internal Medicine and have completed additional training in Endocrinology. Specific clinical experience working with diabetes in pregnancy patients is an asset.
Expressions of interest must be submitted by December 31, 2022 and include up-to-date curriculum vitae, a description of previous specialty and any subspecialty training, and previous working experience.
For further information or to submit your curriculum vitae, contact Dr. Laurence Chau, Chief of Medicine Department, by email to: [email protected]
We thank all applicants for their submissions; however, only qualified candidates will be contacted to attend a pre-application
interview. All appointments are subject to an impact analysis and Board approval.